Skip to content
AnalystLens

CENTENE CORP 8-K Report, Regulation FD Disclosure (Sep 10, 2024)

Reports
Regulation FD
Filing Date
Filed September 10, 2024
Period End
September 10, 2024
Security
CNC
In the record · 2016–202610-K1110-Q328-K217

CNC filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 217 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Jul ’18Jul ’18
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Nov ’22Nov ’22
  4. Leadership change8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed September 10, 2024. Cited figures are marked; the original filing is the authoritative source.

Centene Corporation (CNC) filed an 8-K on September 10, 2024, to disclose information from an investor meeting.

The key takeaway for investors is the reaffirmation of the company's full-year 2024 adjusted diluted earnings per share (EPS) guidance of greater than $6.80a. This indicates management's confidence in achieving its previously stated financial targets for the year.

The filing also reiterates a shift in EPS realization from the third quarter (Q3) to the fourth quarter (Q4) of 2024, with Q3 adjusted diluted EPS projected to be between $1.31b and $1.41. The company further noted positive progress in improving its Medicare Advantage Stars program performance, a key area for future growth and revenue enhancement within its government-backed health insurance offerings.

02—Key points

Key Highlights

  1. Reaffirms 2024 full-year adjusted diluted EPS guidance of greater than $6.80.
  2. Projects Q3 2024 adjusted diluted EPS between $1.31 and $1.41.
  3. Indicates a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4 2024.
  4. Reiterates continued progress in improving Medicare Advantage Stars program performance.
  5. Provides non-GAAP financial measures for a clearer view of ongoing operations and performance trends.
  6. Emphasizes that non-GAAP measures may differ from those used by other companies and should be viewed alongside GAAP information.

03—Questions

Frequently Asked Questions

  1. What is Centene's updated financial outlook for 2024?

    Centene has reaffirmed its full-year 2024 adjusted diluted EPS guidance of greater than $6.80. This guidance indicates management's continued confidence in the company's financial performance for the remainder of the year.

  2. How does the company expect its earnings to be distributed across the third and fourth quarters of 2024?

    Centene expects a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4 2024. Consequently, the projected adjusted diluted EPS for Q3 is between $1.31 and $1.41, with the remaining portion of the full-year EPS expected to be realized in Q4.

  3. What is the status of Centene's Medicare Advantage Stars program?

    The company reiterated that it remains encouraged by the progress made in improving its Medicare Advantage Stars program performance. Strong Stars ratings are crucial for revenue and future growth within the Medicare Advantage segment.

  4. Why does Centene provide non-GAAP financial measures?

    Centene provides non-GAAP financial measures, such as adjusted diluted EPS, because it believes these figures help investors assess the ongoing nature of its operations and measure performance more consistently across periods. These measures are also used internally for performance evaluation and planning.

04—Continue

← View all 8-K filings